This is the mechanistic reason researchers study it separately from native IGF-1: with less protein-binding interference, the analog remains bioavailable roughly 3x longer, giving it an extended half-life of approximately 2030 hours compared to native IGF-1s 1215 hours
These drugs require medical supervision, including monitoring for side effects and periodic reassessment of weight goals
Additionally, the "lowers A1C" claim rests on a result that didn't reach statistical significance
Physicians prescribe GLP-1 agonists such as semaglutide, liraglutide, tirzepatide, and dulaglutide for the management of type 2 diabetes mellitus and weight management for obese patients
Your healthcare provider will tailor the dosage and frequency of semaglutide GLP-1 based on your individual needs, health profile, and progress